In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.

Excerpts from recent editorials in the United States and abroad: ___ Jan. 26 The Washington Post on Trump's “energy emergency” Oil and gas production in the United States is hitting record highs, ...

Samsung Bioepis' Q1 2025 report shows oncology, ophthalmology, and pegfilgrastim biosimilars have gained significant market share, while immunology, filgrastim, epoetin alfa, and insulin glargine ...

For its part, Sanofi released an announcement a day after Novo Nordisk, where it detailed how it would cut the list price of its Lantus product by 78%, as well as establishing a $35 cap on out-of ...

"High list prices also make insulin unaffordable for ... of three big-selling insulin products in the US – Sanofi's Lantus, Novo Nordisk's Novolog, and Lilly's Humalog – by 2024.

It sells products through independent distributors primarily in India.Sanofi India's products viz. Lantus Combiflam Amaryl and Allegra feature in the top 100 pharmaceutical brands in India. The ...

Lantus, Combiflam, Amaryl and Allegra feature ... to Novartis Pharma AG and exit the joint venture. The purchase price agreed to be paid is US Dollars 22.399 million. Simultaneously, Aventis ...

Americans can continue to expect high prices for eggs this year, new estimates show, due to the ongoing avian flu outbreak and inflation. Egg prices are estimated to increase about 20% in 2025 ...

OMAHA, Neb. (AP) — Bird flu is forcing farmers to slaughter millions of chickens a month, pushing U.S. egg prices to more than double their cost in the summer of 2023. And it appears there may ...

And while Peterborough used to be one place people in Toronto came to escape high real estate prices, housing costs have soared there in recent years, just as they have in many parts of the country.

Sanofi SNY reported fourth-quarter 2024 adjusted earnings of 70 cents per American depositary share, which missed the Zacks Consensus Estimate of 71 cents per share. Earnings of €1.31 per share ...